Atypical hyperplasia of the endocervix - problematic issues related to molecular characteristics of adenocarcinoma, risk of progression and metastasis
Abstract
Cervical cancer is considered a multifactorial disease that includes socio-economic, cultural, immunological and epigenetic factors. Tumour precursor lesions, which are the basis for the development of endocervical tumours, have been studied. However, the molecular basis of this process is still under investigation.
References
[1] F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.,” CA Cancer J Clin, vol. 68, no. 6, pp. 394–424, Nov. 2018, doi: 10.3322/caac.21492.
[2] “https://www.ncdc.ge/#/pages/file/ea1784b5-d3d0-4dd9-b29f-1369f5d6bbec”.
[3] A. D. Campos-Parra et al., “Molecular Differences between Squamous Cell Carcinoma and Adenocarcinoma Cervical Cancer Subtypes: Potential Prognostic Biomarkers,” Current Oncology, vol. 29, no. 7, pp. 4689–4702, Jul. 2022, doi: 10.3390/curroncol29070372.
[4] Y. Zhou, W. Wang, K. Hu, and F. Zhang, “Comparison of Outcomes and Prognostic Factors Between Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma Patients After Radical Surgery and Postoperative Adjuvant Radiotherapy,” Cancer Manag Res, vol. Volume 13, pp. 7597–7605, Oct. 2021, doi: 10.2147/CMAR.S329614.
[5] M. Wang, B. Yuan, Z. Zhou, and W. Han, “Clinicopathological characteristics and prognostic factors of cervical adenocarcinoma,” Sci Rep, vol. 11, no. 1, p. 7506, Apr. 2021, doi: 10.1038/s41598-021-86786-y.
